UK government confirms indefinite recognition of CE-marked medical devices

Long-term acceptance of CE marking means devices already cleared for the EU market will not need a separate UK approval route.

The UK government has confirmed that CE-marked medical devices and in vitro diagnostic devices (IVDs) will continue to be accepted in Great Britain on a long-term basis, removing the prospect of a separate approval step for products already cleared for the European market.

The decision covers technologies that patients and the NHS rely on, from insulin pumps and replacement joints to diagnostic tests and surgical equipment, and is intended to help keep supply stable.

Consultation and rationale

The announcement follows a public consultation that ran from 16 February 2026 to 10 April 2026 and drew more than 1,000 responses from patients, healthcare organisations, industry and other respondents.

According to the government, continued recognition avoids duplicated assessment for manufacturers and helps maintain uninterrupted access to medical technologies. More than 90% of medical devices currently registered for use in Great Britain carry a CE mark, meaning they have been assessed and approved for the European market, and that approval has been recognised as providing access to the Great British market.

UKCA route continues

The CE route sits alongside UKCA marking, which continues to operate as the domestic approval pathway for devices placed on the market in Great Britain. Guidance on placing UKCA or CE-marked products on the market in Great Britain is available to manufacturers.

TR

Talia Reiner

Talia Reiner covers power wheelchairs, hospital beds, patient lifts, and orthotic devices as a rehabilitation and home-care equipment analyst for institutional readers. Her assessments examine rated patient load, transfer geometry, battery runtime, serviceability, and care-setting fit against published specifications and maintenance requirements. She helps care-facility planners and home-care equipment buyers compare configuration, service coverage, and total cost of ownership while excluding individualized therapy and consumer shopping advice.